Drug Profile
Fentanyl intranasal - Takeda
Alternative Names: InstanylLatest Information Update: 31 Dec 2021
Price :
$50
*
At a glance
- Originator Nycomed
- Developer Takeda Pharmaceuticals International GmbH
- Class Amides; Benzene derivatives; General anaesthetics; Opioid analgesics; Piperidines; Small molecules
- Mechanism of Action Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Cancer pain
Most Recent Events
- 27 Mar 2012 Nycomed is now called Takeda Pharmaceuticals International GmbH
- 29 Feb 2012 Takeda completes a phase I trial in Healthy volunteers in Germany (NCT01497288)
- 10 Jan 2012 Nycomed completes enrolment in a phase I trial in Healthy volunteers in Germany (NCT01497288)